Company overview
USCC
91330702745812556T
Id2
330700400001924
English Name
Nexchem Pharmaceutical Co., Ltd.
Former names
浙江立信药业有限公司
Chinese Name
浙江耐司康药业有限公司
Entity type
Limited Liability Company (Natural Person Invested or Controlled)
Authorized capital
¥37,444
Phone
+8657982229914
Representative
余斌
Establishment date
23 December 2002
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 14 July 2022 | IN | 29415000 | Azithromycin Ip | Shah Tc Global Exim Llp | IN | Nexchem Pharmaceutical Company Limited | $987,640.02 | |
| 10 May 2022 | IN | 29415000 | Azithromycin | Shah Tc Global Exim Llp | IN | Nexchem Pharmaceutical Company Limited | $944,458.95 | |
| 21 February 2022 | ID | 29419000 | Azitthromycine Dihydrate | PT Bernofarm | ID | Nexchem Pharmaceutical Company Limited | CN | $525,000.00 |
| 10 May 2022 | ID | 29419000 | Azitthromycine Dihydrate | PT Bernofarm | ID | Nexchem Pharmaceutical Company Limited | CN | $350,000.00 |
| 29 July 2022 | IN | 29415000 | Azithromycin Ip | Shah Tc Global Exim Llp | IN | Nexchem Pharmaceutical Company Limited | $342,102.55 | |
| 11 May 2022 | IN | 29415000 | Azithromycin Ip | Shah Tc Global Exim Llp | IN | Nexchem Pharmaceutical Company Limited | $288,996.32 | |
| 25 August 2022 | IN | 29419090 | Clarithromycin Ip | Shah Tc Global Exim Llp | IN | Nexchem Pharmaceutical Company Limited | $257,273.00 | |
| 25 September 2022 | IN | 29415000 | Azithromycin Ip 105 Drums | Shah Tc Global Exim Llp | IN | Nexchem Pharmaceutical Company Limited | $199,828.41 | |
| 24 June 2024 | ID | 29280090 | Benserazide Hydrochloride | PT Dexa Medical | ID | Nexchem Pharmaceutical Company Limited | $132,000.00 | |
| 7 August 2025 | ID | 29280090 | Benserazide Hydrochloride | PT Dexa Medical | ID | Nexchem Pharmaceutical Company Limited | $130,500.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Dexa Medica | buyer | $1,021,100 | 18.08% |
| PT Bernofarm | buyer | $875,000 | 15.49% |
| PT Tatarasa Primatama | buyer | $148,600 | 2.63% |